Literature DB >> 7477654

Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions.

L Gotloib1, V Waisbrut, A Shostak, R Kushnier.   

Abstract

Solutions for peritoneal dialysis (PD), the hyperosmolarity of which is obtained with glucose, have been shown to initiate and maintain a situation of continuous mesothelial cell injury associated with a process of regeneration which also takes place continuously. The present study was done using the in vivo and almost in situ technique of mesothelial cell imprints. Acute exposure to 4.25% glucose solution at pH 5.2 and 7.0 induced higher mitotic activity, defective cytokinesis, and reduced cell viability. Long-term exposure (15 and 30 days) to both 4.25% glucose solutions was associated with a reduced population density, increased surface area, and lower mesothelial cell viability, regardless of the pH. The use of 1.5% glucose fluid showed that this effect was dose related. After 30 days of recovery, mesothelial cells exposed to the high-glucose solution at both pH 5.2 and 7.0 appeared repopulated by small cells and showed evidence of defective cytokinesis. So far, it appears that the alterations observed after long-term exposure of the mesothelium to PD fluid are mainly caused by the high concentration of glucose per se. The additional effects of hyperosmolarity are still unclear, whereas the eventual role of low pH, at least in the experimental model used here, can be defined as less than marginal.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477654     DOI: 10.1159/000188647

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

Review 1.  Peritoneal damage by peritoneal dialysis solutions.

Authors:  Takafumi Ito; Noriaki Yorioka
Journal:  Clin Exp Nephrol       Date:  2008-02-15       Impact factor: 2.801

2.  The solution to better preservation of the peritoneal membrane still lies hidden in the solution.

Authors:  Dirk G Struijk
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

3.  PD Solutions and Peritoneal Health.

Authors:  Yeoungjee Cho; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-31       Impact factor: 8.237

4.  Heme oxygenase-1 attenuates epithelial-to-mesenchymal transition of human peritoneal mesothelial cells.

Authors:  Kitae Bang; Jinuk Jeong; Jong Ho Shin; Ju Hyung Kang; Chang Nam Kim; Hye-Jung Yeom; Myeong Ok Yoon; Jaeseok Yang; Curie Ahn; Jong-Ik Hwang; Mee Young Park; Joo-Heon Kim; Kang Wook Lee
Journal:  Clin Exp Nephrol       Date:  2012-11-14       Impact factor: 2.801

5.  Cellular stress-response modulators in the acute rat model of peritoneal dialysis.

Authors:  Michael Boehm; Helga Bergmeister; Klaus Kratochwill; Regina Vargha; Hans Lederhuber; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

6.  Effect of the peritoneal dialysis prescription on pentosidine in children.

Authors:  Aysun K Bayazit; Beth A Vogt; Katherine M Dell; Ira D Davis; Aytul Noyan; Ali Anarat; Ellis D Avner; Penny Erhard; Miriam F Weiss
Journal:  Pediatr Nephrol       Date:  2003-07-29       Impact factor: 3.714

7.  HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium.

Authors:  Min-A Yu; Kyung-Sook Shin; Jung Hye Kim; Yong-Il Kim; Soon Sup Chung; Sun-Hee Park; Yong-Lim Kim; Duk-Hee Kang
Journal:  J Am Soc Nephrol       Date:  2009-02-04       Impact factor: 10.121

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.